View Item 

Show simple item record

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer
dc.contributor.authorMarck, Eric A.en_US
dc.contributor.authorGolen, Kenneth L.en_US
dc.contributor.authorVermeulen, Peter B.en_US
dc.contributor.authorEynden, Gert G.en_US
dc.contributor.authorLaere, Steven J.en_US
dc.contributor.authorAuwera, Ilseen_US
dc.contributor.authorMerajver, Sofia D.en_US
dc.contributor.authorDam, Peteren_US
dc.contributor.authorDirix, Luc Y.en_US
dc.date.accessioned2006-09-11T14:28:51Z
dc.date.available2006-09-11T14:28:51Z
dc.date.issued2006-02en_US
dc.identifier.citationEynden, Gert G.; Laere, Steven J.; Auwera, Ilse; Merajver, Sofia D.; Marck, Eric A.; Dam, Peter; Vermeulen, Peter B.; Dirix, Luc Y.; Golen, Kenneth L.; (2006). "Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer." Breast Cancer Research and Treatment 95(3): 219-228. <http://hdl.handle.net/2027.42/44235>en_US
dc.identifier.issn1573-7217en_US
dc.identifier.issn0167-6806en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/44235
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16244790&dopt=citationen_US
dc.description.abstractInflammatory breast cancer (IBC) is the most aggressive form of locally advanced breast cancer (LABC). The IBC phenotype is characterized by an infiltrative growth pattern, increased (lymph)angiogenesis and the propensity to invade dermal lymphatics. In pancreatic cancer, interactions between caveolin-1 and RhoC GTPase, a key molecule in causing the IBC phenotype, regulate tumour cell motility and invasion. In this study we sought to investigate the role of caveolin-1 and -2 in IBC cell lines and in human IBC samples.en_US
dc.format.extent429850 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Springer Science+Business Media, Inc.en_US
dc.subject.otherMethylationen_US
dc.subject.otherCaveolin-1en_US
dc.subject.otherCaveolin-2en_US
dc.subject.otherInflammatory Breast Canceren_US
dc.subject.otherRhoC GTPaseen_US
dc.titleOverexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast canceren_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbsecondlevelOphthalmologyen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelObstetrics and Gynecologyen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, Division of Hematology and Oncology, The University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA,en_US
dc.contributor.affiliationumDepartment of Internal Medicine, Division of Hematology and Oncology, The University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA,en_US
dc.contributor.affiliationotherTranslational Cancer Research Group Antwerp, (Lab Pathology, University of Antwerp/University Hospital Antwerp, Edegem; Oncology Center, General Hospital St-Augustinus, Wilrijk), Belgium,en_US
dc.contributor.affiliationotherTranslational Cancer Research Group Antwerp, (Lab Pathology, University of Antwerp/University Hospital Antwerp, Edegem; Oncology Center, General Hospital St-Augustinus, Wilrijk), Belgium,en_US
dc.contributor.affiliationotherTranslational Cancer Research Group Antwerp, (Lab Pathology, University of Antwerp/University Hospital Antwerp, Edegem; Oncology Center, General Hospital St-Augustinus, Wilrijk), Belgium,en_US
dc.contributor.affiliationotherTranslational Cancer Research Group Antwerp, (Lab Pathology, University of Antwerp/University Hospital Antwerp, Edegem; Oncology Center, General Hospital St-Augustinus, Wilrijk), Belgium,en_US
dc.contributor.affiliationotherTranslational Cancer Research Group Antwerp, (Lab Pathology, University of Antwerp/University Hospital Antwerp, Edegem; Oncology Center, General Hospital St-Augustinus, Wilrijk), Belgium,en_US
dc.contributor.affiliationotherTranslational Cancer Research Group Antwerp, (Lab Pathology, University of Antwerp/University Hospital Antwerp, Edegem; Oncology Center, General Hospital St-Augustinus, Wilrijk), Belgium,en_US
dc.contributor.affiliationotherTranslational Cancer Research Group Antwerp, (Lab Pathology, University of Antwerp/University Hospital Antwerp, Edegem; Oncology Center, General Hospital St-Augustinus, Wilrijk), Belgium,en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid16244790en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/44235/1/10549_2005_Article_9002.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s10549-005-9002-1en_US
dc.identifier.sourceBreast Cancer Research and Treatmenten_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
10549_2005_Article_9002.pdf
Size:
419.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.